News
Pfizer boss refuses to testify to EU Parliament COVID panel — again
Related to Pfizer boss refuses to testify to EU Parliament COVID panel — again:
Other Headlines
Coronavirus
UK Covid-19 booster jab offer set to end
More news about Coronavirus
Health & Nutrition
New guidance on childhood obesity urges medication and surgery
More news about Health & Nutrition
Vaccines
Science & Tech
Investors ditch vaccine stocks after Joe Biden says ‘pandemic is over’
More news about Science & Tech
Environment
Netherlands to close up to 3,000 farms to comply with EU rules
More news about Environment
Policy
Pfizer boss refuses to testify to EU Parliament COVID panel — again
More news about Policy
News Archive
Page 1 of 15
-
The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday.The Food and Drug Administration is pushing to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine on Monday, further expediting an earlier timeline for licensing the shot, according to people familiar with the agency’s planning. An F.D.A. spokeswoman declined to comment. The agency had recently set an unofficial deadline for approval of around Labor Day. READ FULL ARTICLE…Continue reading The F.D.A. is aiming to give full approval to Pfizer’s Covid vaccine on Monday.
-
BREAKING: U.S. Coast Guard Academy Plans To ‘Purge’ Covid Unvaxxed CadetsBy Jefferey Jaxen Seven cadets from the United States Coast Guard Academy (USCGA) in New London, CT have found themselves in very hot water, after standing by their religious exemption from the Coast Guard vaccine mandate. While most businesses, the travel industry, and other branches of the armed forces, have backed down from their Covid…Continue reading BREAKING: U.S. Coast Guard Academy Plans To ‘Purge’ Covid Unvaxxed Cadets
-
U.S. FDA grants full approval to Pfizer-BioNTech COVID-19 vaccine without public hearingReuters is reporting the U.S. Food and Drug Administration (F.D.A.) has granted full approval to the Pfizer Inc COVID-19 vaccine that had earned emergency-use authorization (EUA) in December, making it the first to secure such an F.D.A. validation. The full approval marks a regulatory switch for Pfizer’s shot away from an experimental (EUA) therapy. The…Continue reading U.S. FDA grants full approval to Pfizer-BioNTech COVID-19 vaccine without public hearing